Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 116

    1.

    Partial resolution of diabetic macular oedema after systemic treatment with furosemide.

    Ciardella AP.

    Br J Ophthalmol. 2004 Sep;88(9):1224-5. No abstract available. PMID: 15317721 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Optical coherence tomography.

    Kumar A, Sinha S.

    Ophthalmology. 2008 Feb;115(2):417-8; author reply 418. No abstract available. PMID: 18243920 [PubMed - indexed for MEDLINE]Related articles

    3.

    Intravitreal triamcinolone acetonide for the treatment of diffuse diabetic macular oedema--a case report.

    Wang C, Katz BJ, Turner MJ, Hu J, Zhang K.

    Ann Acad Med Singapore. 2006 Feb;35(2):112-4.PMID: 16565766 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Optical coherence tomographic pattern may predict visual outcome after intravitreal triamcinolone for diabetic macular edema.

    Gibran SK, Khan K, Jungkim S, Cleary PE.

    Ophthalmology. 2007 May;114(5):890-4.PMID: 17467527 [PubMed - indexed for MEDLINE]Related articles

    5.

    Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema.

    Writing Committee for the Diabetic Retinopathy Clinical Research Network, Fong DS, Strauber SF, Aiello LP, Beck RW, Callanan DG, Danis RP, Davis MD, Feman SS, Ferris F, Friedman SM, Garcia CA, Glassman AR, Han DP, Le D, Kollman C, Lauer AK, Recchia FM, Solomon SD.

    Arch Ophthalmol. 2007 Apr;125(4):469-80.PMID: 17420366 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.

    Haritoglou C, Kook D, Neubauer A, Wolf A, Priglinger S, Strauss R, Gandorfer A, Ulbig M, Kampik A.

    Retina. 2006 Nov-Dec;26(9):999-1005.PMID: 17151486 [PubMed - indexed for MEDLINE]Related articles

    7.

    Optical coherence tomography and vessel diameter changes after intravitreal bevacizumab in diabetic macular oedema.

    Soliman W, Vinten M, Sander B, Soliman KA, Yehya S, Rahman MS, Larsen M.

    Acta Ophthalmol. 2008 Jun;86(4):365-71. Epub 2007 Nov 17.PMID: 18028237 [PubMed - indexed for MEDLINE]Related articles

    8.

    Intravitreal triamcinolone acetonide for diffuse diabetic macular edema: phase 2 trial comparing 4 mg vs 2 mg.

    Audren F, Lecleire-Collet A, Erginay A, Haouchine B, Benosman R, Bergmann JF, Gaudric A, Massin P.

    Am J Ophthalmol. 2006 Nov;142(5):794-99. Epub 2006 Sep 15.PMID: 16978576 [PubMed - indexed for MEDLINE]Related articles

    9.

    Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study).

    Paccola L, Costa RA, Folgosa MS, Barbosa JC, Scott IU, Jorge R.

    Br J Ophthalmol. 2008 Jan;92(1):76-80. Epub 2007 Oct 26.PMID: 17965109 [PubMed - indexed for MEDLINE]Related articles

    10.

    Intravitreal triamcinolone acetonide for diffuse diabetic macular oedema: 6-month results of a prospective controlled trial.

    Audren F, Erginay A, Haouchine B, Benosman R, Conrath J, Bergmann JF, Gaudric A, Massin P.

    Acta Ophthalmol Scand. 2006 Oct;84(5):624-30.PMID: 16965492 [PubMed - indexed for MEDLINE]Related articles

    11.

    Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography.

    Kim SJ, Equi R, Bressler NM.

    Ophthalmology. 2007 May;114(5):881-9. Epub 2007 Feb 1.PMID: 17275910 [PubMed - indexed for MEDLINE]Related articles

    12.

    Optical coherence tomography: a key to the future management of patients with diabetic macular oedema.

    Massin P, Girach A, Erginay A, Gaudric A.

    Acta Ophthalmol Scand. 2006 Aug;84(4):466-74. Review.PMID: 16879566 [PubMed - indexed for MEDLINE]Related articles

    13.

    Intravitreal triamcinolone versus laser photocoagulation for persistent diabetic macular oedema.

    Ockrim ZK, Sivaprasad S, Falk S, Roghani S, Bunce C, Gregor Z, Hykin P.

    Br J Ophthalmol. 2008 Jun;92(6):795-9. Epub 2008 Apr 17.PMID: 18420749 [PubMed - indexed for MEDLINE]Related articles

    14.

    Intravitreal injection versus sub-Tenon's infusion of triamcinolone acetonide for refractory diabetic macular edema: a randomized clinical trial.

    Bonini-Filho MA, Jorge R, Barbosa JC, Calucci D, Cardillo JA, Costa RA.

    Invest Ophthalmol Vis Sci. 2005 Oct;46(10):3845-9.PMID: 16186372 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    The predictive value of optical coherence tomography after grid laser photocoagulation for diffuse diabetic macular oedema.

    Soliman W, Sander B, Soliman KA, Yehya S, Rahamn MS, Larsen M.

    Acta Ophthalmol. 2008 May;86(3):284-91. Epub 2007 Nov 13.PMID: 18005220 [PubMed - indexed for MEDLINE]Related articles

    16.

    The effect of intravitreal triamcinolone on diabetic macular oedema.

    Krepler K, Wagner J, Sacu S, Wedrich A.

    Graefes Arch Clin Exp Ophthalmol. 2005 May;243(5):478-81. Epub 2004 Dec 7.PMID: 15586288 [PubMed - indexed for MEDLINE]Related articles

    17.

    Intravitreal triamcinolone for macular oedema: efficacy in relation to aetiology.

    Sørensen TL, Haamann P, Villumsen J, Larsen M.

    Acta Ophthalmol Scand. 2005 Feb;83(1):67-70.PMID: 15715560 [PubMed - indexed for MEDLINE]Related articles

    18.

    Two-year results of intravitreal triamcinolone acetonide injection for the treatment of diabetic macular edema.

    Batioğlu F, Ozmert E, Parmak N, Celik S.

    Int Ophthalmol. 2007 Oct;27(5):299-306. Epub 2007 Apr 24.PMID: 17453151 [PubMed - indexed for MEDLINE]Related articles

    19.

    Regression of sight-threatening macular edema in type 2 diabetes following treatment with the anti-tumor necrosis factor monoclonal antibody infliximab.

    Sfikakis PP, Markomichelakis N, Theodossiadis GP, Grigoropoulos V, Katsilambros N, Theodossiadis PG.

    Diabetes Care. 2005 Feb;28(2):445-7. No abstract available. PMID: 15677814 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Central serous chorioretinopathy following vitrectomy with intravitreal triamcinolone acetonide for diabetic macular oedema.

    Imasawa M, Ohshiro T, Gotoh T, Imai M, Iijima H.

    Acta Ophthalmol Scand. 2005 Feb;83(1):132-3. No abstract available. PMID: 15715582 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data